Jill Hale
Adult Health · Fredericksburg, VANPI 1972812147
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,046 of the $4,877 with a category attached, or 83.0%. 32 manufacturers reported payments, led by Cvrx, Inc. at 24.7% of the total. 2025 is the largest year on record at $2,330, more than ten times the $150 reported in 2021.
Across 125 payments — averaging $39.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cvrx, Inc.$1K
- Medtronic$1K
- Boston Scientific$370
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$279
- Philips North America LLC$269
- Amgen$202
- plus $1K from 26 others
What the payments were for
- Travel & lodging$83117%
- Food & beverage$4,04683%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cvrx, Inc. | 15 | $1,206 |
| Medtronic | 29 | $1,069 |
| Boston Scientific | 8 | $370 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $279 |
| Philips North America LLC | 7 | $269 |
| Amgen | 7 | $202 |
| Atricure, Inc. | 3 | $175 |
| Novo Nordisk | 6 | $167 |
| Abiomed | 2 | $155 |
| Heartflow, Inc. | 2 | $122 |
| Edwards Lifesciences | 2 | $118 |
| Biosense Webster, Inc. | 3 | $118 |
| Pfizer | 5 | $102 |
| Irhythm Technologies, Inc. | 1 | $95 |
| Cardiva Medical, Inc. | 3 | $73 |
| Novartis | 3 | $44 |
| Merck | 3 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $28 |
| Abbott | 1 | $27 |
| AstraZeneca | 1 | $25 |
| Vifor Pharma, Inc. | 2 | $25 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Impulse Dynamics (USA) Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| Bayer | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Scpharmaceuticals Inc. | 1 | $13 |
| Altathera Pharmaceuticals LLC | 1 | $11 |
| Vivaquant Inc, Dba Rhythm Express | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,877 in reported general payments places this provider in the 85th percentile of 368 adult health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 248 | $250,312 |
| XareltoRivaroxaban | 45 | $53,981 |
| Repatha SureclickEvolocumab | 31 | $34,180 |
| EntrestoSacubitril/Valsartan | 30 | $26,515 |
| FarxigaDapagliflozin Propanediol | 12 | $8,707 |
| Flecainide Acetate | 91 | $3,767 |
| Metoprolol Succinate | 213 | $3,677 |
| Midodrine Hcl | 21 | $2,494 |
| Atorvastatin Calcium | 119 | $1,446 |
| Rosuvastatin Calcium | 124 | $1,312 |
| Potassium Chloride | 21 | $1,090 |
| Ranolazine ErRanolazine | 11 | $1,068 |
| Amiodarone Hcl | 47 | $1,039 |
| Clonidine | 11 | $1,028 |
| Amlodipine Besylate | 167 | $947 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $102 | $250,312248 claims |
| Johnson & JohnsonXarelto | $14 | $53,98145 claims |
| NovartisEntresto | $44 | $26,51530 claims |
| AstraZenecaFarxiga | $25 | $8,70712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 368 adult health providers in Virginia.
Other adult health in Fredericksburg
- Chelsea KoskovichFredericksburg$34K
- Heidi TaftFredericksburg$7K
- Ophelia MensahFredericksburg$4K
- Christine KesslerFort Belvoir$107K
- Denise BruenCharlottesville$45K
- Theresa Harrington StukusFairfax$40K
- Brittany BrownLynchburg$14K
- Colleen DieringVirginia Beach$13K
- Veronica HughesRichmond$12K
- Nicole SellersNorfolk$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.